RANA THERAPEUTICS INC has a total of 124 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are IONIS PHARMACEUTICALS INC, BIOMARIN TECH BV and REGENERTECH PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 28 | |
#2 | United States | 23 | |
#3 | Canada | 15 | |
#4 | EPO (European Patent Office) | 15 | |
#5 | China | 12 | |
#6 | Australia | 9 | |
#7 | Brazil | 5 | |
#8 | Republic of Korea | 5 | |
#9 | Israel | 4 | |
#10 | Singapore | 3 | |
#11 | Hong Kong | 2 | |
#12 | Japan | 2 | |
#13 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Medical technology | |
#6 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Enzymes | |
#6 | Peptides | |
#7 | Object sterilising | |
#8 | Fermentation | |
#9 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Krieg Arthur M | 68 |
#2 | Subramanian Romesh | 66 |
#3 | Mcswiggen James | 65 |
#4 | Lee Jeannie T | 59 |
#5 | Ozsolak Fatih | 32 |
#6 | Barsoum James | 9 |
#7 | Uhlmann Eugen | 8 |
#8 | Woo Caroline | 8 |
#9 | Severgnini Mariano | 6 |
#10 | Romesh Subramanian | 5 |
Publication | Filing date | Title |
---|---|---|
WO2017075030A1 | Methods and compositions for increasing smn expression | |
WO2015023938A1 | Epigenetic regulators of frataxin | |
US2016201064A1 | Compositions and methods for modulating expression of frataxin | |
CA2921459A1 | Oligonucleotides targeting euchromatin regions of genes | |
CA2921457A1 | Heterochromatin forming non-coding rnas | |
KR20160027968A | Compositions and methods for modulating foxp3 expression | |
WO2013173637A1 | Compositions and methods for modulating gene expression | |
AU2013262656A1 | Compositions and methods for modulating UTRN expression | |
WO2013173652A1 | Compositions and methods for modulating gene expression | |
US2015232836A1 | Compositions and methods for modulating gene expression | |
CA2873772A1 | Compositions and methods for modulating bdnf expression | |
CN104540947A | Compositions and methods for modulating SMN gene family expression | |
AU2013262709A1 | Compositions and methods for modulating MECP2 expression | |
CA2873801A1 | Compositions and methods for modulating apoa1 and abca1 expression | |
US2015159161A1 | Compositions and methods for modulating pten expression |